Niagen Bioscience Inc. (NAGE)
NAGE trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.58
-1.90% on the day
Market cap
$204.1M
Micro cap
Revenue · 2025
$129.4M
+29.9% on 2024
Net income · 2025
$17.4M
13.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NAGE on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001386570 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $129.4M |
| Net income | $17.4M |
| Operating income | $16.3M |
| Net margin | 13.4% |
| Operating margin | 12.6% |
| Revenue growth | +29.9% |
| Cash | Not in SEC XBRL data |
| Total assets | $106.4M |
| P/E (computed) | 11.7× |
| P/S (computed) | 1.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-07-10 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-08-04 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 979 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.29 | -1.38% | $265.8M |
| SNDL | SNDL Inc. Common Shares | $1.16 | -0.85% | $285.5M |
| USNA | USANA Health Sciences Inc. | $15.46 | +3.41% | $285.6M |
| CGC | Canopy Growth Corporation Common Shares | $0.7625 | +0.66% | $322.6M |
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier